Daily News Podcast

FDA approval for 2 HIV drugs


 

The FDA approves the once-daily oral drugs Delstrigo and Pifeltro for HIV-1 infection. Also today, emicizumab beats factor VIII prophylaxis by a wide margin, orodental issues are often associated with facial port-wine stains, and epilepsy often accompanies congenital Zika infections. Subscribe to the MDedge Daily News wherever you get your podcasts.
Amazon Alexa
Apple Podcasts
Spotify

Recommended Reading

Telangiectatic Patch on the Neck
MDedge Dermatology
5 digital HIPAA myths
MDedge Dermatology
Screen for cervical cancer based on age, risk
MDedge Dermatology
Is it time for PCPs to take over chronic HCV?
MDedge Dermatology
Rivaroxaban data abound at ESC 2018
MDedge Dermatology
New MI definition for infarction vs injury
MDedge Dermatology
Lorcaserin shows cardiovascular safety
MDedge Dermatology
Lung function decline linked to cardiovascular risk
MDedge Dermatology
Product News: 09 2018
MDedge Dermatology
Rivaroxaban beats aspirin for VTE
MDedge Dermatology